Application 214679
- Type
- NDA
- Sponsor
- AZURITY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EPRONTIA | TOPIRAMATE | SOLUTION; ORAL | 15MG | No | No |
| 002 | EPRONTIA | TOPIRAMATE | SOLUTION; ORAL | 25MG | No | No |
| 003 | EPRONTIA | TOPIRAMATE | SOLUTION; ORAL | 50MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 52652-9001 | Eprontia | Topiramate | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 52652-9001 | Eprontia | Topiramate | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 52652-9001 | Eprontia | Topiramate | Azurity Pharmaceuticals, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85306 | SUPPL | 2026-03-09 |
| 85305 | SUPPL | 2026-03-09 |
| 85355 | SUPPL | 2026-03-06 |
| 81583 | SUPPL | 2025-03-17 |
| 81566 | SUPPL | 2025-03-14 |
| 78545 | SUPPL | 2024-05-22 |
| 78544 | SUPPL | 2024-05-22 |
| 78519 | SUPPL | 2024-05-20 |
| 72487 | SUPPL | 2022-10-28 |
| 72484 | SUPPL | 2022-10-27 |
| 71716 | ORIG | 2022-08-04 |
| 69289 | ORIG | 2021-11-10 |
| 69275 | ORIG | 2021-11-08 |